Back to search

Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year

Data up to Jan 2025

Published1999
Citations633
References27

Total Citations Per Year

Abstract

References (27)

Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease

1959 • 14,850 citations

Functional evaluation : Barthel index

1965 • 12,604 citations

Tissue Plasminogen Activator for Acute Ischemic Stroke

1995 • 10,997 citations

Interobserver agreement for the assessment of handicap in stroke patients.

1988 • 5,690 citations

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1995 • 3,456 citations

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)

1998 • 3,417 citations

'Malignant' Middle Cerebral Artery Territory Infarction

1996 • 1,284 citations

Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group.

1994 • 1,188 citations

Guidelines for Thrombolytic Therapy for Acute Stroke: A Supplement to the Guidelines for the Management of Patients With Acute Ischemic Stroke

1996 • 721 citations

Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke

1995 • 627 citations

Survival and recurrence following stroke. The Framingham study.

1982 • 550 citations

Thrombolytic Therapy with Streptokinase in Acute Ischemic Stroke

1996 • 546 citations

Generalized Efficacy of t-PA for Acute Stroke

1997 • 540 citations

Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community

1994 • 472 citations

Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke

1998 • 414 citations

Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association.

1996 • 345 citations

Streptokinase for Acute Ischemic Stroke With Relationship to Time of Administration

1996 • 337 citations

Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group

1996 • 302 citations

Observer variability in assessing impaired consciousness and coma.

1978 • 290 citations

Practice Advisory [RETIRED]

1996 • 231 citations

Use of a Global Test for Multiple Outcomes in Stroke Trials With Application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial

1996 • 228 citations

Epidemiological characteristics of lacunar infarcts in a population.

1991 • 180 citations

Reliability of the activities of daily living scale and its use in telephone interview.

1987 • 179 citations

Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials

1991 • 129 citations

A Systems Approach to Immediate Evaluation and Management of Hyperacute Stroke

1997 • 119 citations

Health-related information postdischarge: Telephone versus face-to-face interviewing

1994 • 104 citations

Telephone Interview for Stroke Outcome Assessment

1994 • 64 citations

Cited By (0)

Loading...
Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year (1999) – New England Journal of Medicine | Metascience Observatory Explorer